BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11437849)

  • 1. Hearing evaluation with distortion-product otoacoustic emissions in young patients undergoing haemodialysis.
    Stavroulaki P; Nikolopoulos TP; Psarommatis I; Apostolopoulos N
    Clin Otolaryngol Allied Sci; 2001 Jun; 26(3):235-42. PubMed ID: 11437849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hemodialysis on hearing using pure-tone audiometry and distortion-product otoacoustic emissions.
    Ozturan O; Lam S
    ORL J Otorhinolaryngol Relat Spec; 1998; 60(6):306-13. PubMed ID: 9742277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of early cochlear damage in young patients with type 1 diabetes detected by distortion product otoacoustic emissions.
    Botelho CT; Carvalho SA; Silva IN
    Int J Audiol; 2014 Jun; 53(6):402-8. PubMed ID: 24564623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cochlear sensitivity in children with chronic kidney disease and end-stage renal disease undergoing hemodialysis.
    Renda R; Renda L; Selçuk ÖT; Eyigör H; Yılmaz MD; Osma Ü
    Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2378-83. PubMed ID: 26590002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deterioration in Distortion Product Otoacoustic Emissions in Auditory Neuropathy Patients With Distinct Clinical and Genetic Backgrounds.
    Kitao K; Mutai H; Namba K; Morimoto N; Nakano A; Arimoto Y; Sugiuchi T; Masuda S; Okamoto Y; Morita N; Sakamoto H; Shintani T; Fukuda S; Kaga K; Matsunaga T
    Ear Hear; 2019; 40(1):184-191. PubMed ID: 29688962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pure-tone threshold estimation from extrapolated distortion product otoacoustic emission I/O-functions in normal and cochlear hearing loss ears.
    Boege P; Janssen T
    J Acoust Soc Am; 2002 Apr; 111(4):1810-8. PubMed ID: 12002865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distortion product otoacoustic emissions in an industrial setting.
    Korres GS; Balatsouras DG; Tzagaroulakis A; Kandiloros D; Ferekidou E; Korres S
    Noise Health; 2009; 11(43):103-10. PubMed ID: 19414930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Input-output functions of the nonlinear-distortion component of distortion-product otoacoustic emissions in normal and hearing-impaired human ears.
    Zelle D; Lorenz L; Thiericke JP; Gummer AW; Dalhoff E
    J Acoust Soc Am; 2017 May; 141(5):3203. PubMed ID: 28599560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Distortion product of otoacoustic emissions in normal hearing and sensorineural hearing loss].
    Schlögel H; Stephan K; Böheim K; Welzl-Müller K
    HNO; 1995 Jan; 43(1):19-24. PubMed ID: 7890546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measuring and analyzing of otoacoustic emission tests of a family with genetic progressive sensorineural hearing loss].
    Yu H; Ke XM; Yu DL; Li Q; Liu YH; Ding GY
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 14(4):157-9. PubMed ID: 12541488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distortion product otoacoustic emissions as a prognostic factor for idiopathic sudden sensorineural hearing loss.
    Chao TK; Chen TH
    Audiol Neurootol; 2006; 11(5):331-8. PubMed ID: 16983184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transiently evoked and distortion-product otoacoustic emissions. Comparison of results from normally hearing and hearing-impaired human ears.
    Probst R; Harris FP
    Arch Otolaryngol Head Neck Surg; 1993 Aug; 119(8):858-60. PubMed ID: 8343248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-frequency hearing influences lower-frequency distortion-product otoacoustic emissions.
    Arnold DJ; Lonsbury-Martin BL; Martin GK
    Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):215-22. PubMed ID: 10037289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term changes of hearing and distortion product otoacoustic emissions in sudden sensorineural hearing loss.
    Park H; Lee Y; Park M; Kim J; Na B; Shin J
    Otol Neurotol; 2010 Aug; 31(6):862-6. PubMed ID: 20601916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
    Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
    Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.